- £220.56m
- £232.97m
- £231.08m
- 90
- 67
- 73
- 93
Annual income statement for Supreme, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 122 | 131 | 156 | 221 | 231 |
| Cost of Revenue | |||||
| Gross Profit | 33 | 38.5 | 40.9 | 63.5 | 73.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 109 | 114 | 140 | 189 | 199 |
| Operating Profit | 13.6 | 17 | 15.4 | 32 | 32.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 13 | 16.3 | 14.4 | 30.1 | 30.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.84 | 13.7 | 12 | 22.4 | 23.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.84 | 13.7 | 12 | 22.4 | 23.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.84 | 13.7 | 12 | 22.4 | 23.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.104 | 0.117 | 0.085 | 0.181 | 0.187 |
| Dividends per Share |